Premium
Treatment of chronic spontaneous urticaria with benralizumab: Report of primary endpoint per‐protocol analysis and exploratory endpoints
Author(s) -
Bernstein Jonathan A.,
Singh Umesh,
Rao Marepalli B.,
Berendts Karen,
Zhang Xiang,
Mutasim Diya
Publication year - 2021
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/all.14713
Subject(s) - benralizumab , clinical endpoint , protocol (science) , medicine , information retrieval , immunology , computer science , alternative medicine , clinical trial , pathology , mepolizumab , eosinophil , asthma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom